Nathan Herrmann, MD

  • 13Articles
  • 58.7KReads
  • 1999–2020Active
  • 52Collaborators
  • 2.3KCitations

About

Nathan Herrmann, MD is a contributing author on Psychiatrist.com. Nathan Herrmann has authored or co-authored 13 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 1999 and 2020. Their work focuses on Alzheimer Disease, Depression (MDD), Neurology, Psychiatry, and Dementia.

Publications

JCP
Original Research

Lithium and Renal Function in Older Adults

August 18, 2020

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs...
, , , et al
JCP
Meta-Analysis

Cannabinoids for Agitation and Aggression in AD

January 29, 2019

Given the limited efficacy and questionable safety profiles of current pharmacologic treatments of agitation in Alzheimer's disease (AD), the therapeutic potential of natural and synthetic cannabinoids are being explored...
, , , et al
JCP
Original Research

Prevention of Mild Cognitive Impairment

November 27, 2018

Depression in older adults is associated with a greater risk of dementia as well as mild cognitive impairment (MCI). This study aimed to identify possible risk factors for developing...
, , , et al
JCP
Article

Lithium Monitoring in Older Adults

November 20, 2018

Lithium treatment, while effective for mood disorders, necessitates frequent drug level and renal monitoring in older patients to prevent serious adverse events. Read this article to see if older...
, , , et al
JCP
Original Research

Lithium Use and Chronic Kidney Disease in Older Adults

August 1, 2017

Could mood-stabilizing medications be increasing patients' risk of developing kidney disease? This large, nested case-control study looks at the degree of risk associated with lithium and valproate treatment in...
, , , et al
JCP
Letter to the Editor

Dr Mazereeuw and Colleagues Reply

August 24, 2016

, ,
JCP
Meta-Analysis

Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials

November 25, 2015

, , , et al
JCP
Original Research

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

April 3, 2013

, , , et al
JCP
Original Research

Major Depressive Disorder Predicts Completion, Adherence, and Outcomes in Cardiac Rehabilitation: A Prospective Cohort Study of 195 Patients With Coronary Artery Disease

November 2, 2010

, , , et al
JCP
Original Research

A Randomized Controlled Trial of Antidepressant Continuation for Major Depression Following Traumatic Brain Injury

April 20, 2010

, , , et al
JCP
Original Research

Current Prescription Patterns and Safety Profile of Irreversible Monoamine Oxidase Inhibitors: A Population-Based Cohort Study of Older Adults

October 20, 2009

, , , et al
JCP
Original Research

Benzodiazepine Use and Driving: A Meta-Analysis

April 21, 2009

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe